Working… Menu

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00004122
Recruitment Status : Completed
First Posted : May 21, 2004
Last Update Posted : February 1, 2013
National Cancer Institute (NCI)
Information provided by:
Roswell Park Cancer Institute

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 2001
Study Completion Date : No date given